World Leading Formulation Development. The Expertise to Deliver Results.
Established in 2002 by Professor Mike Rubinstein, Quay Pharma is an independent, privately owned company with the scientific.
Preclinical formulation and analysis of Active Pharmaceutical Ingredients (APIs), including those that present particular challenges.
We operate from three sites, two are 15km apart, one in England and the other, our head office Quay House, in North Wales. We have just opened.
In-house capabilities offered, and is especially valuable where drugs show poor solubility or bioavailability, or require modified or targeted.
Experienced in formulation development, currently one of the few companies licensed for the clinical manufacture of live.
Phase 1 Clinical Trials
All of the services required to bring an API into clinical use in the fastest and most cost-effective way, including unique Fast Track into Man.
Analytical and quality control services, inc analytical method development and validation, and accelerated, formal and.
Phase 11/111 Clinical Trials
GMP clinical manufacturing services covering Phase I formulations, large-scale Phase II, Phase III and post-marketing studies.